ProterixBio

United States
Billerica, Massachusetts, United States, 01821

Company profile

ProterixBio company profile

Developer of proprietary blood-based biomarker tests to transform the management of chronic respiratory diseases. The company is focused on addressing the unmet need for tools to provide a real-time, biological assessment of a patient’s disease state. ProterixBio's products will enable health care providers to better manage their patients and avoid unnecessary hospitalizations, leading to improved outcomes and reduced health care costs. It was founded in 2002 and headquartered in Billerica, Massachusetts.

Business identity

Contact email
[email protected]
Phone number
+119789016700
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2002-01-01, Year

Headquarters

Postal code
01821
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Private Equity
Funding rounds
8
Total equity funding
$69.5M
Last funding
Private Equity / $18.8M / 2013-07-09
Last equity funding
Private Equity / $18.8M
Investors
7
Lead investors
1
Founders
2
Articles
4

Founders and investors

Founders

Edward CrawleyMark Lundstrom

Lead investors

Blackfin Technology

Investors

F2 VenturesMF CapitalMorningsideNew Science VenturesNew York Angels